Published in Neurology on October 01, 1985
Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry (2003) 1.56
Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction. Eur J Nucl Med Mol Imaging (2007) 1.49
Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr Dis Treat (2008) 1.21
Neuroimaging and therapeutics in movement disorders. NeuroRx (2005) 1.17
PET: its clinical role in neurology. J Neurol Neurosurg Psychiatry (1991) 0.98
Cerebral mitochondrial metabolism in early Parkinson's disease. J Cereb Blood Flow Metab (2008) 0.92
Vessel-specific quantification of blood oxygenation with T2-relaxation-under-phase-contrast MRI. Magn Reson Med (2014) 0.91
Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry (1988) 0.89
SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry (1992) 0.89
Abnormal movement related potentials in patients with lesions of basal ganglia and anterior thalamus. J Neurol Neurosurg Psychiatry (1994) 0.88
Neuroimaging in Parkinson's disease. NeuroRx (2004) 0.88
Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons. Front Neuroanat (2014) 0.86
Recent advances in PET imaging for evaluation of Parkinson's disease. Eur J Nucl Med Mol Imaging (2010) 0.84
Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study. J Neurol Neurosurg Psychiatry (1998) 0.82
Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations. J Neurol Neurosurg Psychiatry (1986) 0.80
Subcortical type cognitive impairment in herpes zoster encephalitis. J Neurol (1997) 0.79
Positron emission tomography imaging of transplant function. NeuroRx (2004) 0.78
PET and movement disorders. J Neurol Neurosurg Psychiatry (1989) 0.78
Pre-conditioning with low-level laser (light) therapy: light before the storm. Dose Response (2014) 0.77
HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness. J Neurol Neurosurg Psychiatry (1994) 0.76
PET studies of cerebral metabolism in Parkinson disease. J Bioenerg Biomembr (2009) 0.75
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
The composite genome of the legume symbiont Sinorhizobium meliloti. Science (2001) 9.11
Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell (1997) 8.23
Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med (1996) 6.11
Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr (1980) 4.94
Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med (1995) 3.93
In-vivo measurement of activated microglia in dementia. Lancet (2001) 3.51
Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci (2000) 3.50
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav (2007) 3.29
Evidence for striatal dopamine release during a video game. Nature (1998) 3.28
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A (2000) 3.09
Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet (1984) 3.05
Cowpox: reservoir hosts and geographic range. Epidemiol Infect (1999) 2.93
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
Nucleotide sequence and predicted functions of the entire Sinorhizobium meliloti pSymA megaplasmid. Proc Natl Acad Sci U S A (2001) 2.59
Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. J Infect Dis (1991) 2.52
Genomic evidence for a complete sexual cycle in Candida albicans. Proc Natl Acad Sci U S A (2001) 2.52
Central nervous pathways mediating angina pectoris. Lancet (1994) 2.38
Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A (2000) 2.32
Glucose utilization in vivo by human pulmonary neoplasms. Cancer (1987) 2.29
Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol (1992) 2.27
Synergy between medical informatics and bioinformatics: facilitating genomic medicine for future health care. J Biomed Inform (2004) 2.25
Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Engl J Med (1984) 2.24
Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry (1992) 2.21
Transmission dynamics of a zoonotic pathogen within and between wildlife host species. Proc Biol Sci (1999) 2.11
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. II. Fractionation: recovery and reoxygenation. Br J Radiol (1968) 2.09
Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain (1981) 2.08
BVD virus genotype 2 detected in British cattle. Vet Rec (2002) 2.05
Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology (2002) 2.00
Measurement of gastric emptying using the scintillation camera and 129Cs. Br J Radiol (1970) 1.92
Prevalence of small inversions in yeast gene order evolution. Proc Natl Acad Sci U S A (2000) 1.90
Greenhouse warming by CH4 in the atmosphere of early Earth. J Geophys Res (2000) 1.90
Azotobacter vinelandii NIFL is a flavoprotein that modulates transcriptional activation of nitrogen-fixation genes via a redox-sensitive switch. Proc Natl Acad Sci U S A (1996) 1.89
The in vitro inhibition of growth of intracellular Listeria monocytogenes by lymphocyte products. Cell Immunol (1973) 1.87
The relationship of knee and ankle weakness to falls in nursing home residents: an isokinetic study. J Am Geriatr Soc (1987) 1.86
Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab (1993) 1.84
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry (1986) 1.84
Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75
Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res (1992) 1.74
Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method. J Cereb Blood Flow Metab (1983) 1.73
A cross-sectional validation study of the FICSIT common data base static balance measures. Frailty and Injuries: Cooperative Studies of Intervention Techniques. J Gerontol A Biol Sci Med Sci (1995) 1.71
Hydrocarbon exposure and Parkinson's disease. Neurology (2000) 1.70
Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet (1984) 1.70
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry (2005) 1.69
Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer (1989) 1.68
Leaf photosynthetic traits scale with hydraulic conductivity and wood density in Panamanian forest canopy trees. Oecologia (2004) 1.64
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain (1996) 1.64
Assessment of regional ventilation by continuous inhalation of radioactive krypton-81m. Br Med J (1975) 1.62
Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology (1993) 1.59
Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain (1983) 1.58
Supersensitivity and gastric emptying after vagotomy. Gut (1970) 1.58
Emergency asthma inhalers in school. Arch Dis Child (2003) 1.56
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology (1997) 1.55
Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogues. Biochemistry (1978) 1.55
Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. J Cereb Blood Flow Metab (1995) 1.54
Gastric emptying of solid meals after truncal vagotomy and pyloroplasty in human subjects. Gut (1972) 1.52
Activation of the human brain by monetary reward. Neuroreport (1997) 1.52
The DNA region around the c-myc gene and its amplification in human tumour cell lines. Oncogene (1994) 1.50
High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites. Biochemistry (1995) 1.50
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol (1997) 1.49
Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits. Psychiatr Serv (1996) 1.49
Psychosocial correlates of survival in advanced malignant disease? N Engl J Med (1985) 1.48
Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med (1999) 1.48
Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol (1993) 1.48
Tracheo-innominate artery fistula after percutaneous tracheostomy: three case reports and a clinical review. Br J Anaesth (2005) 1.48
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology (2000) 1.47
Effect of long-term beta2-agonist dosing on human cardiac beta-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. J Nucl Cardiol (1998) 1.45
Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. J Nucl Cardiol (2001) 1.45
Impact of complementary parathyroid scintigraphy and ultrasonography on the surgical management of hyperparathyroidism. Surgery (1996) 1.43
Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation. Br J Cancer (1993) 1.42
Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol (1997) 1.42
Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry (1998) 1.42
Detection of thirty-second cognitive activations in single subjects with positron emission tomography: a new low-dose H2(15)O regional cerebral blood flow three-dimensional imaging technique. J Cereb Blood Flow Metab (1993) 1.41
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol (1990) 1.39
Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1992) 1.38
Antiretroviral adherence and use of alternative therapies among older HIV-infected adults. J Natl Med Assoc (2001) 1.37
[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology (1999) 1.36
Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med (1994) 1.36
The effect of cowpox virus infection on fecundity in bank voles and wood mice. Proc Biol Sci (1997) 1.35
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol (1997) 1.34
Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. Cancer Res (1992) 1.33
Infrequent genetic exchange and recombination in the mitochondrial genome of Candida albicans. J Bacteriol (2001) 1.32
Changes in brain activation associated with reward processing in smokers and nonsmokers. A positron emission tomography study. Exp Brain Res (2001) 1.32
Evaluation of wound irrigation by pulsatile jet and conventional methods. Ann Surg (1978) 1.31
Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med (1998) 1.31
Pure amnesia after unilateral left polar thalamic infarct: topographic and sequential neuropsychological and metabolic (PET) correlations. J Neurol Neurosurg Psychiatry (1994) 1.30
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology (1997) 1.30
The continuous inhalation of oxygen-15 for assessing regional oxygen extraction in the brain of man. Br J Radiol (1976) 1.30
Separation and characterization of a subset of human T8+ cells which function as antigen-presenting and contrasuppressor cells. Immunology (1985) 1.28
A method for measuring the absolute sensitivity of positron emission tomographic scanners. Eur J Nucl Med (1991) 1.27
How does the human brain deal with a spinal cord injury? Eur J Neurosci (1998) 1.27
In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain (2001) 1.26
Parametric image reconstruction using spectral analysis of PET projection data. Phys Med Biol (1998) 1.26
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med (2001) 1.25